Opthea Ltd (OPT):企業の財務・戦略的SWOT分析

◆英語タイトル:Opthea Ltd (OPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15017
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vascular endothelial growth factors. Its pipeline products include VEGF-C, VEGF-D and VEGFR-3. Opthea’s lead compound, OPT-302 is used in combination with existing VEGF-A inhibitors in patients with age-related macular degeneration and diabetic macular edema. The company’s VEGF-D diagnostics is a prognostic indicator of number of tumor types, and VEGF-C diagnostics, an indicator of survival rate. It partners with healthcare and diagnostic centers. Circadian is headquartered in Melbourne, Victoria, Australia.

Opthea Ltd Key Recent Developments

Oct 29,2018: Opthea Provides Update on Wet AMD and Diabetic Macular Edema Key Opinion Leader Forum
Oct 26,2018: Opthea Reports Positive Three-Month Data from Phase 1b Dose Escalation Study for OPT-302 in Diabetic Macular Edema
Oct 24,2018: Opthea To Present Update at the Ophthalmology Innovation Summit in Chicago

This comprehensive SWOT profile of Opthea Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Opthea Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Opthea Ltd – Key Information
Opthea Ltd – Overview
Opthea Ltd – Key Employees
Opthea Ltd – Key Employee Biographies
Opthea Ltd – Key Operational Heads
Opthea Ltd – Major Products and Services
Opthea Ltd – History
Opthea Ltd – Company Statement
Opthea Ltd – Locations And Subsidiaries
Opthea Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Opthea Ltd – Business Description
Opthea Ltd – Corporate Strategy
Opthea Ltd – SWOT Analysis
SWOT Analysis – Overview
Opthea Ltd – Strengths
Opthea Ltd – Weaknesses
Opthea Ltd – Opportunities
Opthea Ltd – Threats
Opthea Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Opthea Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Opthea Ltd, Key Information
Opthea Ltd, Key Ratios
Opthea Ltd, Share Data
Opthea Ltd, Major Products and Services
Opthea Ltd, History
Opthea Ltd, Key Employees
Opthea Ltd, Key Employee Biographies
Opthea Ltd, Key Operational Heads
Opthea Ltd, Other Locations
Opthea Ltd, Subsidiaries
Opthea Ltd, Key Manufacturing facilities
Opthea Ltd, Key Competitors
Opthea Ltd, SWOT Analysis
Opthea Ltd, Ratios based on current share price
Opthea Ltd, Annual Ratios
Opthea Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Opthea Ltd, Performance Chart
Opthea Ltd, Ratio Charts

★海外企業調査レポート[Opthea Ltd (OPT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shuwen Biotech Co Ltd:企業の製品パイプライン分析2018
    Summary Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech dev …
  • Berkshire Hathaway Energy:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Huaneng Power International Inc:企業の発電所・SWOT分析2018
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Esprinet SpA (PRT):企業の財務・戦略的SWOT分析
    Esprinet SpA (PRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas …
  • Ecopetrol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Ecopetrol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Ecopetrol SA (Ecopetrol) is a vertically integrated oil and gas company that carries out exploration, development and production of oil and gas. It is also involved in refining of crude oil to produce p …
  • Paramedical Srl:企業の製品パイプライン分析2018
    Summary Paramedical Srl (Paramedical) is a medical equipment company that manufactures clinical chemistry, turbidimetry and instruments for laboratories. The company’s products include in vitro diagnostics and equipment, automated immunoassay, brochure regents and instruments, centrifuges, chemistry …
  • Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Unum Therapeutics Inc (UMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …
  • Atrion Corp (ATRI):企業の財務・戦略的SWOT分析
    Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health Plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunction in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug can …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Alsalam Aerospace Industries:企業の戦略・SWOT・財務情報
    Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report Summary Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Deluxe Corporation:企業の戦略・SWOT・財務情報
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • A2B Australia Limited
    A2B Australia Limited - Strategy, SWOT and Corporate Finance Report Summary A2B Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mexco Energy Corp:企業の財務・戦略的SWOT分析
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆